Cha Myoungil 4
4 · TANDEM DIABETES CARE INC · Filed May 23, 2025
Insider Transaction Report
Form 4
Cha Myoungil
Director
Transactions
- Exercise/Conversion
Common Stock
2025-05-22$20.64/sh+4,387$90,548→ 11,950 total - Exercise/Conversion
Restricted Stock Unit
2025-05-22−4,387→ 0 total→ Common Stock (4,387 underlying) - Award
Restricted Stock Unit
2025-05-21+8,759→ 8,759 total→ Common Stock (8,759 underlying)
Footnotes (4)
- [F1]Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F3]RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
- [F4]Awarded on May 21, 2025 pursuant to the 2023 Plan.